Jaime Valentin
Overview
Explore the profile of Jaime Valentin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montalban-Hernandez K, Cantero-Cid R, Casalvilla-Duenas J, Avendano-Ortiz J, Marin E, Lozano-Rodriguez R, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884505
Background: The cancer cell fusion theory could be one of the best explanations for the metastasis from primary tumours. Methods: Herein, we co-cultured colorectal cancer (CRC) stem cells with human...
2.
Cantero-Cid R, Montalban-Hernandez K, Guevara J, Pascual-Iglesias A, Pulido E, Casalvilla J, et al.
World J Gastrointest Oncol
. 2022 Feb;
14(1):295-318.
PMID: 35116118
Background: Colorectal cancer (CRC) accounts for 9.4% of overall cancer deaths, ranking second after lung cancer. Despite the large number of factors tested to predict their outcome, most patients with...
3.
Montalban-Hernandez K, Cantero-Cid R, Lozano-Rodriguez R, Pascual-Iglesias A, Avendano-Ortiz J, Casalvilla-Duenas J, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359797
Colorectal cancer (CRC) is the second most deadly and third most commonly diagnosed cancer worldwide. There is significant heterogeneity among patients with CRC, which hinders the search for a standard...
4.
Avendano-Ortiz J, Lozano-Rodriguez R, Martin-Quiros A, Maroun-Eid C, Terron-Arcos V, Montalban-Hernandez K, et al.
J Immunol
. 2021 Jun;
207(1):162-174.
PMID: 34183364
According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be...
5.
Avendano-Ortiz J, Lozano-Rodriguez R, Martin-Quiros A, Maroun-Eid C, Terron V, Valentin J, et al.
Heliyon
. 2020 Dec;
6(12):e05635.
PMID: 33283062
Increased cytokine levels, acute phase reactants and immune checkpoint expression changes have been described in patients with Coronavirus Disease 2019 (COVID-19). Here, we have reported a monocyte polarization towards a...
6.
Aguirre L, Montalban-Hernandez K, Avendano-Ortiz J, Marin E, Lozano R, Toledano V, et al.
Oncoimmunology
. 2020 Sep;
9(1):1773204.
PMID: 32923132
The 'cancer cell fusion' theory is controversial due to the lack of methods available to identify hybrid cells and to follow the phenomenon in patients. However, it seems to be...
7.
Vela M, Del Rosal T, Perez-Martinez A, Valentin J, Casas I, Pozo F, et al.
Sci Rep
. 2019 Dec;
9(1):18792.
PMID: 31827202
Infection is the leading cause of non-relapse-related mortality after allogeneic haematopoietic stem cell transplantation (HSCT). Altered functions of immune cells in nasal secretions may influence post HSCT susceptibility to viral...
8.
Vela M, Bueno D, Gonzalez-Navarro P, Brito A, Fernandez L, Escudero A, et al.
Front Immunol
. 2019 Aug;
10:1814.
PMID: 31428099
Sarcoma is one of the most severe forms of pediatric cancer and current therapies -chemotherapy and surgery- fail to eradicate the disease in half of patients. Preclinical studies combining new...
9.
Escudero A, Martinez-Romera I, Fernandez L, Valentin J, Gonzalez-Vicent M, Vicario J, et al.
Biol Blood Marrow Transplant
. 2018 Aug;
24(12):2493-2500.
PMID: 30145228
Preliminary data suggest that ex vivo T cell-depleted matched related donor (MRD) hematopoietic stem cell transplantation (HSCT) is feasible and confers a clinically beneficial reduction in graft-versus-host disease. Classically, T...
10.
Perruccio K, Sisinni L, Perez-Martinez A, Valentin J, Capolsini I, Massei M, et al.
Biol Blood Marrow Transplant
. 2018 Aug;
24(12):2549-2557.
PMID: 30067953
Human herpesvirus-6 (HHV-6) infection is increasingly recognized among allogeneic hematopoietic stem cell transplantation (HSCT) recipients, with 30% at risk of reactivation in the haploidentical setting. It has been associated with...